Ignite Creation Date:
2025-12-25 @ 5:19 AM
Ignite Modification Date:
2025-12-26 @ 4:26 AM
Study NCT ID:
NCT00080327
Status:
COMPLETED
Last Update Posted:
2013-11-11
First Post:
2004-03-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Organization:
Study Overview
Official Title:
A Placebo-Controlled Study of Three Doses of Aripiprazole in Patients With Acute Schizophrenia
Status:
COMPLETED
Status Verified Date:
2008-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to evaluate three doses of aripiprazole versus placebo in patients with an acute episode of schizophrenia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: